BioLife Solutions (BLFS) Tops Q1 EPS by 4c ; Offers Guidance
BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $21.6 million versus the consensus estimate of $22.17 million.
GUIDANCE:
BioLife Solutions sees FY2025 revenue of $95.5-99 million, versus the consensus of $97.03 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
